Induction treatment in high-grade B-cell lymphoma with a concurrent <i>MYC</i> and <i>BCL2</i> and/or <i>BCL6</i> rearrangement: a systematic review and meta-analysis. The gene discussed is BCL2; the disease is B-cell non-Hodgkin lymphoma.